News & Events

Filter Year   Keywords   > Submit

Page 2 3

KaloBios‚?? KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology

19 / 09 / 2013

Human Safety and PK/PD Data from Phase 1 Study of KB001 Supports Ongoing Phase 2 Clinical Trial of KB001-A in Cystic Fibrosis

> Read More

National - Telstra Australian Business Awards: Health.com.au

23 / 08 / 2013

Health.com.au has been awarded Telstra‚??s National Business of the year award in the Start- Up category, after winning the Telstra Victorian Start- Up of the year in July.

> Read More

Cowen: Four EU C-Pulse Patients Implanted; U.S. Enrollment On Tap

08 / 08 / 2013

We reiterate our Outperform rating on Sunshine Heart primarily due to our view that the C-Pulse could prove to be a disruptive solution for NYHA Class III and IV ambulatory CHF patients.

> Read More

Cannacord Genuity: Solid progress across the board; maintain 12.50PT and reiterate buy

08 / 08 / 2013

Sunshine Heart announced solid progress in trial site enrollment in both the US and Europe. During the quarter, the company activated three new sites for the COUNTER HF US pivotal trial, activated two new sitesfor the OPTIONS HF EU post -market study, and has made significant progress in its product development efforts. In the US, SSH is on track to activate a total of 22 centers by year end and eight centers in Europe,both in line with our expectations. Reimbursement efforts are tracking to plan in both regions, and early data from the first four C - Pulse implants in Europe validate the potential benefits of this device demonstrated in the feasibility trial.

> Read More

 
Displaying records 1-25 of 56